CEMIP (cell migration-inducing protein) can elevate the level of SLC7A11 in PCa cells by promoting NRF2 phosphorylation and nuclear localization, thereby promoting cellular ferroptosis resistance [35]. The gene discussed is SLC7A11; the disease is posterior cortical atrophy.